Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes.

Cancers (Basel) · 2022 · PMC9740463 · PMID 36497490

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Interestingly, the neoadjuvant chemotherapy subgroup showed a trend of improved survival in favor of HIPEC (61.8 vs. 48.2, p -value 0.4; 17.4 vs. 15.4 months, p -value 0.04).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.